Hims & Hers Welcomes FDA Veteran to Board, Strengthens Quality Leadership
Key Highlights Deb Autor, former FDA Deputy Commissioner, joins Hims & Hers Board of Directors. Janet Stevens, pharmaceutical quality…
Browsing Tag
AstraZeneca
20 posts
Entact Bio Appoints Ruben Tommasi, Ph.D., as Chief Scientific Officer
Key Highlights Entact Bio appoints Ruben Tommasi, Ph.D., as Chief Scientific Officer. Dr. Tommasi brings 30 years of drug…
Pillar Biosciences Partners with AstraZeneca to Expand Access to NGS Liquid Biopsy Panels
Key Highlights Partnership to expand molecular testing across European and UK markets. Focus on rapid, in-house cancer diagnosis…
BridgeBio Oncology Therapeutics Appoints Dr. Yong Ben as Chief Medical and Development Officer
Key Highlights Yong (Ben) Ben, MD, appointed as Chief Medical and Development Officer at BBOT. Dr. Ben brings…
Seaport Therapeutics Appoints Dr. David Wheadon to Board of Directors
Key Highlights Seaport Therapeutics appoints Dr. David Wheadon to its Board of Directors. Dr. Wheadon has over three decades…
Precigen, Inc. Appoints Phil Tennant as Chief Commercial Officer
Key Highlights Phil Tennant appointed as Chief Commercial Officer at Precigen. Focus on commercial readiness for PRGN-2012 gene…
Selkirk Pharma Appoints Colleen Dixon as New CEO
Key Highlights Selkirk Pharma announces Colleen Dixon as new CEO. Dixon brings over 30 years of biopharma experience.…
Nocion Therapeutics Welcomes New Leadership to Drive Phase 2b Clinical Trial
Key Highlights Dr. Catherine Bonuccelli joins Scientific Advisory Board. Joan Shaw appointed Senior VP, Clinical Operations. Taplucainium Phase 2b clinical trial…
MOMA Therapeutics Welcomes New Leadership Team Members
Key Highlights Marc Ballas, M.D. appointed as SVP, head of clinical development. Adam Thomas joins as chief people and experience…
CinRx Pharma Closes $73M Financing to Boost High-Impact Medicines
Key Highlights CinRx Pharma secures $73 million, total funds raised now $176 million. Funds to advance portfolio programs…